Custom antibody development

We offer world-leading antibody development platforms based on a proprietary RabMAb® rabbit monoclonal platform, a phage display platform (AxioMx), and a next-generation sequencing platform (NGS-RabMAb®)

The lab has contacted me today regarding ab43. They have said that the information they gave me yesterday was wrong and that this antibody has indeed been tested in IP and therefore is guaranteed to function. Read More

I have contacted the lab regarding the protocol used to do IP for ab43. Unfortunately, I have found out that we have no information regarding how this antibody functions in IP and therefore we cannot guarantee th...

Thank you for your enquiry. To our knowledge, ab43 has not yet been tested for application in IF. The antibody was originally characterized for use in Western blotting and IP.
We have another ERCC1 antibody that hasn't been tested yet in IF either,...